Menu

Publikationen

 

Klinische Publikationen

  • Kinnen A, Klaschik S, Neumann C, Egger EV, Mustea A, Soehle M, Frede S, Velten M, Coburn M, Hilbert T (2021) Gene expression in the Angiopoietin/TIE axis is altered in peripheral tissue of ovarian cancer patients: A prospective observational study. Life Sciences 274:119345
  • Erben P, Becker C, Tsaur I, Stope MB, Todenhöfer T (2021) Molecular subtypes of urothelial carcinoma of the bladder-background and clinical relevance. Urologe A 60:81-88
  • Egger EK, Stope MB, Recker F, Könsgen D, Landsberg J, Fröhlich A, Abramian A, Mustea A (2021) Lower genital tract melanomas: Staging, predictors of outcome and new therapeutic options. Anticancer Res 41:999-1004
  • Abazid A, Holstein N, Machemehl T, Stope MB, Hauer T (2021) Das Zebra unter den Divertikulitiden. Der Chirurg 92:374-376
  • Gelbrich N, Stope MB, Bekeschus S, Weigel M, Burchardt M, Zimmermann U (2020) BK virus-induced nephritis and cystitis after matched unrelated donor stem cell transplantation: a case report. Clin Case Rep 8:2838–2841
  • Recker F, Weber E, Strizek B, Gembruch U, Seibel A (2020) Lung Sonography in Obstetrics during COVID-19. Geburtshilfe Frauenheilkd 80:1026–1032
  • Emons G, Mustea A, Tempfer C (2020) Tamoxifen and endometrial cancer: a Janus-headed drug. Cancers 12:2535
  • Marnitz S, Tsunoda AT, Martus P, Vieira M, Affonso RJ, Nunes J, Budach V, Hertel H, Mustea A, Sehouli J, Scharf JP, Ulrich U, Ebert A, Piwonski I, Kohler C (2020) Surgical versus clinical staging prior to primary chemoradiation in patients with cervical cancer FIGO stages IIB-IVA: oncologic results of a prospective randomized international multicenter (Uterus-11) intergroup study. Int J Gynecol Cancer 30:1855-1861
  • Woelber L, Bommert M, Prieske K, Fischer I, Zu Eulenburg C, Vettorazzi E, Harter P, Jueckstock J, Hilpert F, de Gregorio N, Iborra S, Sehouli J, Ignatov A, Hillemanns P, Fuerst S, Strauss HG, Baumann K, Beckmann M, Mustea A, Meier W, Wimberger P, Hanker L, Canzler U, Fehm T, Luyten A, Hellriegel M, Kosse J, Heiss C, Hantschmann P, Mallmann P, Tanner B, Pfisterer J, Mahner S, Schmalfeldt B, Jaeger A (2020) Pelvic Lymphadenectomy in Vulvar Cancer - Does it make sense? Geburtshilfe Frauenheilkd 80:1221-1228
  • Marnitz S, Waltar T, Köhler C, Mustea A, Schömig-Markiefka B (2020) The brave new world of endometrial cancer: Future implications for adjuvant treatment decisions. Strahlenther Onkol 196:963-972
  • Egger EK, Kohls N, Stope MB, Condic M, Keyver-Paik MD, Könsgen D, Hilbert T, Klaschik S, Exner D, Vilz T, Mustea A (2020) Risk factors for severe complications in ovarian cancer surgery. In Vivo 34:3361-3365
  • Ralser DJ, Strizek B, Kupczyk P, Stoffel-Wagner B, Altengarten J, Müller A, Woelfle J, Gembruch U, Klingmueller D, Merz WM, Paschkowiak-Christes A (2020) Obstetric and neonatal outcome of pregnancy in carney complex: A case report. Front Endocrinol 11:296
  • Fröhlich A, Niebel D, Fietz S, Egger E, Buchner A, Sirokay J, Landsberg J (2020) Talimogene laherparepvec treatment to overcome loco-regional acquired resistance to immune checkpoint blockade in tumor stage IIIB-IV M1c melanoma patients. Cancer Immunol Immunother 69:759-769
  • Hoffmann B, Blaivas M, Abramowicz JS, Bachmann Nielsen M, Badea R, Braden B, Cantisani V, Chammas MC, Cui XW, Dong Y, Gilja OH, Hari R, Lamprecht H, Nisenbaum H, Nolsøe CP, Nürnberg D, Prosch H, Radzina M, Recker F, Sachs A, Saftoiu A, Serra A, Vinayak S, Westerway S, Chou YH, Dietrich CF (2020) Medical Student Ultrasound Education, a WFUMB Position Paper, Part II. A consensus statement by ultrasound societies. Med Ultrason 22:220-229
  • Klapdor R, Hillemanns P, Wölber L, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst S, Strauss H, Baumann K, Thiel F, Mustea A, Meier W, Harter P, Wimberger P, Hanker L, Schmalfeld B, Mahner S (2020) Association between obesity and vulvar cancer recurrence: an analysis of the AGO-CaRE-1 study. Int J Gynecol Cancer 30:920-926
  • Scheck M, Velten M, Klaschik S, Soehle M, Frede S, Gehlen J, Hoch J, Mustea A, Hoeft A, Hilbert T (2020) Differential modulation of endothelial cell function by fresh frozen plasma. Life Sci 254:117780
  • Strizek B, Gottschalk I, Recker F, Weber E, Flöck A, Gembruch U, Geipel A, Berg C (2020) Vesicoamniotic shunting for fetal megacystis in the first trimester with a  Somatex intrauterine shunt. Arch Gynecol Obstet 302:133-140
  • Fröhlich A, Hoffmann F, Niebel D, Egger E, Kukuk GM, Toma M, Sirokay J, Bieber T, Landsberg J (2020) Talimogene Laherparepvec in Advanced Mucosal Melanoma of the Urethra Upon Primary Resistance on Immune Checkpoint Inhibition: A Case Report. Frontiers in Oncology 10:611
  • Gehlen J, Klaschik S, Neumann C, Keyver-Paik MD, Mustea A, Soehle M, Frede S, Velten M, Hoeft A, Hilbert T (2020) Dynamic changes of angiopoietins and endothelial nitric oxide supply during fluid resuscitation for major gyn-oncological surgery: a prospective observation. J Transl Med 18:48
  • Kramer A, Meinke M, Patzelt A, Stope MB, Lademann J, Jacobs K (2020) Perspektiven physikalischer Verfahren der Antiseptik und Desinfektion. Hygiene & Medizin 45:39-45
  • Klinkmann G, Stope MB, Meyer A (2020) Cytokine adsorption as a promising option for septic shock and multiple organ failure due to Candida infection and decompensated type 1 diabetes mellitus. Artif Organs 44:522-525
  • Harter P, Sehouli J, Lorusso D, Reuss A, Vergote I, Marth C, Kim JW, Raspagliesi F, Lampe B, Aletti G, Meier W, Cibula D, Mustea A, Mahner S, Runnebaum IB, Schmalfeldt B, Burges A, Kimmig R, Scambia G, Greggi S, Hilpert F, Hasenburg A, Hillemanns P, Giorda G, von Leffern I, Schade-Brittinger C, Wagner U, du Bois A (2019) A randomized trial of lymphadenectomy in patients with advanced ovarian neoplasms. N Engl J Med 380:822-832
  • Mustea A, Holthaus B, Elmeligy H, Krüger-Rehberg S, Trojnarska D, Alwafai Z, Sternberg J, Stope MB, Kohlmann T, Meinhold-Heerlein I, Koensgen D (2019) Comparison of laparoscopy-assisted vaginal hysterectomy as endoscopic single-station surgery and conventional laparoscopic hysterectomy - surgical effects on safety and quality of life. Gynecol Surg 16:9
  • Riedel F, Weiss M, Stope MB (2019) Neue Möglichkeiten in der gynäkologischen Onkologie - kaltes physikalisches Plasma. Gynäkologe 52:144-146
  • Bailer B, Recker F, Matuschek E (2019) Basiswissen PoCUS - Point-of-Care-Ultraschall lernen und sinnvoll einsetzen. Thieme Verlag. 1. Aufl. ISBN: 9783132426962
  • Klaschik S, Gehlen J, Neumann C, Keyver-Paik MD, Soehle M, Frede S, Velten M, Hoeft A, Hilbert T (2019) Network of mediators for vascular inflammation and leakage is dysbalanced during cytoreductive surgery for late-stage ovarian cancer. Mediators Inflamm 2019:5263717
  • Budde MK, Kuhn W, Keyver-Paik MD, Bootz F, Kalff JC, Müller SC, Bieber T, Brossart P, Vatter H, Herrlinger U, Wirtz DC, Schild HH, Kristiansen G, Pietsch T, Aretz S, Geiser F, Radbruch L, Reich RH, Strassburg CP, Skowasch D, Essler M, Ernstmann N, Landsberg J, Funke B, Schmidt-Wolf IGH (2019) A matched-pair analysis on survival and response rates between German and non-German cancer patients treated at a Comprehensive Cancer Center. BMC Cancer 19:1024
  • Dietrich CF, Hoffmann B, Abramowicz J, Badea R, Braden B, Cantisani, V, Chammas MC, Cui XW, Dong Y, Gilja OH, Hari R, Nisenbaum H, Nicholls D, Nolsoe CP, Nürnberg D, Prosch H, Radzina M, Recker F, Sachs A, Saftoiu A, Serra A, Sweet L, Vinayak S, Westerway S, Chou YH, Blaivas M (2019) Medical student ultrasound education: A WFUMB position paper, part I. Ultrasound Med Biol 45:271-281
  • Gelbrich N, Stope MB, Waldburger N, Breitsprecher R, Burchardt M, Zimmermann U (2019) Muscle invasive urinary bladder squamous cell carcinoma in a patient with clean intermittent self-catheterization: A case report. J Urol Ren Dis 4:1168
  • Polterauer S, Schwameis R, Grimm C, Hillemanns P, Jückstock J, Hilpert F, de Gregorio N, Hasenburg A, Sehouli J, Fürst ST, Strauß HG, Baumann K, Thiel F, Mustea A, Harter P, Wimberger P, Kölbl H, Reinthaller A, Woelber L, Mahner S (2019) Lymph node ratio in inguinal lymphadenectomy for squamous cell vulvar cancer: Results from the AGO-CaRE-1 study. Gynecol Oncol 153:286-291
  • Fischer J, Stope MB (2019) Euthanasia and resuscitation in clinical everyday life - an ethical view from a deontological and consequentialist perspective. Am J Pallia Med Care 1:1-3
  • Schmalfeldt B, Brambs C, Burges A, El-Balat A, Emons G, Fink D, Fotopoulou C, Gropp-Meier M, Hanker LC, Harter P, Hasenburg A, Hauptmann S, Hilpert F, Kimmig R, Kommoss S, Kurzeder C, Mahner S, Marmé F, Mayr D, Meier W, Meinhold-Heerlein I, Mustea A, Ortmann O, Oskay-Özcelik G, Pfisterer J, Pölcher M, Runnebaum IB, Schröder W, Tanner B, Wagner U, Wimberger P, Sehouli J (2019) What is the evidence for lymphadenectomy in presumed early ovarian cancer? Arch Gynecol Obstet 299:1-5
  • Koscielny A, Ko A, Egger EK, Kuhn W, Kalff JC, Keyver-Paik MD (2019) Prevention of anastomotic leakage in ovarian cancer debulking surgery and its impact on overall survival. Anticancer Res 39:5209-5218
  • Fischer J, Stope MB, Gümbel D, Hakenberg O, Burchardt M, Dräger DL (2019) Einfluss von Kultur und Religion auf die Therapie von Krebspatienten. Urologe A 58:1179-1184
  • Denschlag D, Ackermann S, Battista MJ, Cremer W, Egerer G, Follmann M, Haas H, Harter P, Hettmer S, Horn LC, Juhasz-Boess I, Kast K, Köhler G, Kröncke T, Lindel K, Mallmann P, Meyer-Steinacker R, Mustea A, Petru E, Reichardt P, Schmidt D, Strauss HG, Tempfer C, Thiel F, Ulrich U, Vogl T, Vordermark D, Gass P, Beckmann MW (2019) Sarcoma of the uterus. Guideline of the DGGG and OEGGG (S2k Level, AWMF Register Number 015/074, February 2019). Geburtshilfe Frauenheilkd 79:1043-1060
  • Gelbrich N, Stope MB, Burchardt M (2019) Kaltes atmosphärisches Plasma für die urologische Tumortherapie. Urologe A 58:673-679
  • Emons G, Tempfer C, Battista MJ, Mustea A, Vordermark D (2019) Uterus Commission of the AGO adjuvant radiotherapy and/or chemotherapy for endometrial cancer, status as at 2019: Opinion of the Uterus Commission of the Gynecological Oncology Working Group (AGO). Geburtshilfe Frauenheilkd 79:1273-1277
  • Welz J, Keyver-Paik MD, Gembruch U, Merz WM (2019) Self-reported physical, mental, and reproductive sequelae after treatment of abnormally invasive placenta: a single-center observational study. Arch Gynecol Obstet 300:95-101
  • Gelbrich N, Stope MB (2019) Physikalisches Plasma in der chirurgischen Uroonkologie. Krankenhaus und Management 38:9
 

Translationale experimentelle Publikationen

  • Tsaur I, Erben P, Stope MB, Becker C, Todenhöfer T (2021) Fachgruppe „Molekulare Urologie“ der „Arbeitsgruppe urologische Forschung“ der DGU. Spectrum Urologie 1/2021: 22-23
  • Freud E, Miebach L, Stope MB, Bekeschus S (2021) Hypochlorous acid selectively promotes toxicity and the expression of danger signals in human abdominal cancer cells. Oncol Rep 45:71
  • Stope MB (2021) Phosphorylation of histone H2A.X as a DNA-associated biomarker (Review). World Acad Sci J 3:31
  • Bekeschus S, Clemen R, Haralambiev L, Niessner F, Grabarczyk P, Weltmann KD, Menz J, Stope MB, von Woedtke T, Gandhirajan R, Schmidt A (2021) The plasma-induced leukemia cell death is dictated by the ROS chemistry and the HO-1/CXCL8 axis. IEEE Transactions on Radiation and Plasma Medical Sciences 5:398-411
  • Vasko T, Bonas C, Hoffmann J, Bertram J, Quinete N, Schettgen T, Esser A, Stope MB, Fietkau K, Leijs M, Baron J, Kraus T, Voigt A, Ziegler P (2020) Metabolic activation and toxicological evaluation of polychlorinated biphenyls in Drosophila melanogaster. Sci Rep 10:21587
  • Haralambiev L, Neuffer O, Nitsch A, Kross NC, Bekeschus S, Hinz P, Mustea A, Ekkernkamp A, Gümbel D, Stope MB (2020) Inhibition of angiogenesis by treatment with cold atmospheric plasma as a promising therapeutic approach in oncology. Int J Mol Sci 21:7098
  • Stope MB, Benouahi R, Sander C, Haralambiev L, Nitsch A, Egger E, Mustea A (2020) Protherapeutic effects and inactivation of mammary carcinoma cells by a medical argon plasma device. Anticancer Res 40:6205-6212
  • Rüger M, Kipp E, Schubert N, Schröder N, Pufe T, Stope MB, Kipp M, Blume C, Tauber SC, Brandenburg LO (2020) The formyl peptide receptor agonist Ac2-26 alleviates neuroinflammation in a mouse model of pneumococcal meningitis. J Neuroinflammation 17:325
  • Könsgen D, Klinkmann G, Kaul A, Diesing K, Sehouli J, Braicu I, Sümnig A, Erb HHH, Stope MB, Mustea A (2020) Soluble heat-shock protein 27 in blood serum is a non-invasive prognostic biomarker for ovarian cancer. Eur J Obstet Gynecol Reprod Biol 255:154–159
  • Stope MB (2020) Plasma oncology - Physical plasma as innovative tumor therapy. J Cancer Biol 1:53-56
  • Kletschkus K, Haralambiev L, Mustea A, Bekeschus S, Stope MB (2020) Review of innovative physical therapy methods: introduction to the principles of cold physical plasma. In Vivo 34:3103-3107
  • Ralser DJ, Kumar S, Borisov O, Sarig O, Richard G, Wolf S, Krawitz PM, Sprecher E, Kreiß M, Betz RC (2020) Identification of a founder mutation in KRT14 associated with Naegeli-Franceschetti-Jadassohn-syndrome. Br J Dermatol 183:756-757
  • Kletschkus K, Gelbrich N, Burchardt M, Kramer A, Bekeschus S, Stope MB (2020) Emission of ultraviolet radiation from 220 to 280 nm by a cold physical plasma generating device. Health Phys 119:153-159
  • Jacoby JM, Strakeljahn S, Nitsch A, Bekeschus S, Hinz P, Mustea A, Ekkernkamp A, Tzvetkov MV, Haralambiev L, Stope MB (2020) An innovative therapeutic option for the treatment of skeletal sarcomas: elimination of osteo- and Ewing's sarcoma cells using physical gas plasma. Int J Mol Sci 21:4460
  • Haralambiev L, Bandyophadyay A, Suchy B, Weiss M, Kramer A, Bekeschus S, Ekkernkamp A, Mustea A, Kaderali L, Stope MB (2020) Determination of immediate vs. kinetic growth retardation in physically plasma-treated cells by experimental and modelling data. Anticancer Res 40: 3743-3749
  • Haralambiev L, Nitsch A, Einenkel R, Muzzio DO, Gelbrich N, Burchardt M, Zygmunt M, Ekkernkamp A, Stope MB, Gümbel D (2020) The effect of cold atmospheric plasma on the membrane permeability of human osteosarcoma cells. Anticancer Res 40:841-846
  • Brünnert D, Langer C, Zimmermann L, Bargou RC, Burchardt M, Chatterjee M, Stope MB (2020) The heat shock protein 70 inhibitor VER155008 suppresses the expression of HSP27, HOP and HSP90β and the androgen receptor, induces apoptosis, and attenuates prostate cancer cell growth. J Cell Biochem 121:407-417
  • Haralambiev L, Wien L, Gelbrich N, Lange J, Bakir S, Kramer A, Burchardt M, Ekkernkamp A, Gümbel D, Stope MB (2020) Cold atmospheric plasma inhibits the growth of osteosarcoma cells by induction of apoptosis, independent of the device used. Oncol Lett 19:283-290
  • Haralambiev L, Nitsch A, Jacoby JM, Strakeljahn S, Bekeschus S, Mustea A, Ekkernkamp A, Stope MB (2020) Cold atmospheric plasma treatment of chondrosarcoma cells affects proliferation and cell membrane permeability. Int J Mol Sci 21:2291
  • Daragan G, Hoffmann J,Vasko T, Mustea A, Burchardt M, Kraus T, Stope MB*, Ziegler P* (2019) Dirty deeds done dirt cheap: sensitization of prostate cancer cells to abiraterone treatment using hydroxylated polychlorinated biphenyls. Invest New Drugs 38:541–545
  • Kletschkus K, Haralambiev L, Nitsch A, Pfister F, Klinkmann G, Kramer A, Bekeschus S, Mustea A, Stope MB (2020) The application of a low-temperature physical plasma device operating under atmospheric pressure leads to the production of toxic NO2. Anticancer Res 40:2591-2599
  • Bekeschus S, Ressel V, Freund E, Gelbrich N, Mustea A, Stope MB (2020) Gas plasma-treated prostate cancer cells augment myeloid cell activity and cytotoxicity. Antioxidants 9:323
  • Klümper N, Ralser DJ, Bawden EG, Landsberg J, Zarbl R, Kristiansen G, Toma M,  Ritter M, Hölzel M, Ellinger J, Dietrich D (2020) LAG3 (LAG-3, CD223) DNA methylation correlates with LAG3 expression by tumor and immune cells, immune cell infiltration, and overall survival in clear cell renal cellcarcinoma. J Immunother Cancer 8:e000552
  • Feil L, Koch A, Utz R, Ackermann M, Barz J, Stope MB, Krämer B, Wallwiener D, Brucker SY, Weiss M (2020) Cancer-selective treatment of cancerous and non-cancerous human cervical cell models by a non-thermally operated electrosurgical argon plasma device. Cancers 12:1037
  • ​​​​​​Weiss M, Barz J, Ackermann M, Utz R, Ghoul A, Weltmann KD, Stope MB, Wallwiener D, Schenke-Layland K, Oehr C, Brucker S, Loskill P (2019) Dose-dependent tissue-level characterization of a medical atmospheric pressure argon plasma jet. ACS Appl Mater Interfaces 11:19841-19853
  • Stope MB, Weiss M, Popp SL, Joffroy C, Buck MB, Mustea A, Brucker S, Wallwiener D, Knabbe C (2019) The pleiotropic factor Y-box binding protein-1 enhances the anti-proliferative efficacy of 4-hydroxytamoxifen and fulvestrant on breast cancer cells in vitro. Eur J Gynaecol Oncol 40:16-18
  • Ralser DJ, Takeuchi H, Fritz G, Basmanav FB, Effern M, Sivalingam S, El-Shabrawi-Caelen L, Degirmentepe EN, Kocatürk E, Singh M, Booken N, Spierings NMK, Schnabel V, Heineke A, Knuever J, Wolf S, Wehner M, Tronnier M, Leverkus M, Tantcheva-Poor I, Wenzel J, Oji V, Has C, Hölzel M, Frank J, Haltiwanger RS, Betz RC (2019) Altered notch signaling in Dowling-Degos disease: Additional mutations in POGLUT1 and further insights into disease pathogenesis. J Invest Dermatol 139:960-964
  • Reuter A, Sckell A, Brandenburg LO, Burchardt M, Kramer A, Stope MB (2019) Overexpression of microRNA-1 in prostate cancer cells modulates the blood vessel system of an in vivo Hen's Egg Test-Chorioallantoic Membrane model. In Vivo 33:41-46
  • Holstein S, Venz S, Junker H, Walther R, Stope MB, Zimmermann U (2019) Nicotinamide N-methyltransferase and its precursor substrate methionine directly and indirectly control malignant metabolism during progresssion of renal cell carcinoma. Anticancer Res 39:5427-5436
  • Knuever J, Persa OD, Illerhaus A, Ralser DJ, Hartmann K, Betz RC, Tantcheva-Poor I (2019): Mast cell activation in Dowling-Degos disease. Br J Dermatol 181:1312-1314
  • Bekeschus S, Schütz C, Nießner F, Wende K, Weltmann KD, Gelbrich N, Woedtke T, Schmidt A, Stope MB (2019) Elevated H2AX phosphorylation observed with kINPen plasma treatment is not caused by ROS-mediated DNA damage but is the consequence of apoptosis. Oxid Med Cell Longev 2019:8535163
  • Nitsch A, Haralambiev L, Einenkel R, Muzzio DO, Zygmunt MT, Ekkernkamp A, Burchardt M, Stope MB (2019) Determination of in vitro membrane permeability by analysis of intracellular and extracellular fluorescein signals in renal cells. In Vivo 33:1767-1771
  • Freund E, Moritz J, Stope MB, Seebauer C, Schmidt A, Bekeschus S (2019) Plasma-derived reactive species shape a differentiation profile in human monocytes. Appl Sci 9:2530
  • Abazid A, Martin B, Choinowski A, McNeill RV, Brandenburg LO, Ziegler P, Zimmermann U, Burchardt M, Erb H, Stope MB (2019) The androgen receptor antagonist enzalutamide induces apoptosis, dysregulates the heat shock protein system, and diminishes the androgen receptor and estrogen receptor β1 expression in prostate cancer cells. J Cell Biochem 120:16711-16722
  • Ahrend H, Daeschlein G, Grove E, Paditz M, Mustea A, Burchardt M, Stope MB (2019) MicroRNA-20a-3p and microRNA-20a-5p exhibit anti-proliferative activities in a melanoma in vitro model. SDRP Journal of Cellular and Molecular Physiology 3:1-7
  • Rottach AM, Ahrend H, Martin B, Walther R, Zimmermann U, Burchardt M, Stope MB (2019) Cabazitaxel inhibits prostate cancer cell growth by inhibition of androgen receptor and heat shock protein expression. World J Urol 37:2137–2145
  • Haralambiev L, Wien L, Gelbrich N, Kramer A, Mustea A, Burchardt M, Ekkernkamp A, Stope MB, Gümbel D (2019) Effects of cold atmospheric plasma on the expression of chemokines, growth factors, TNF superfamily members, interleukins, and cytokines in human osteosarcoma cells. Anticancer Res 39:151-157
  • Gelbrich N, Nitsch A, Burchardt M, Stope MB (2019) Kaltes atmosphärisches Plasma - Antineoplastische Effekte auf Nierenzellkarzinom-Zellen. Urologische Nachrichten 09/2019:5
 

Hochschuldidaktische Publikationen

  • Recker F, Riedel F, Stope MB, Mustea A, Weiss M, Jennebach J (2020) Der Masterplan Medizinstudium 2020 und die Implementierung des Nationalen Kompetenzbasierten Lernzielkatalogs Medizin - Chancen und Herausforderungen für die Gynäkologie und Geburtshilfe. Geburtshilfe Frauenheilkunde 80:570-573
  • Recker F, Schulmeyer C, Becker L, Weiss M (2020) PJ-Wahlfach in der Corona-Krise. Frauenarzt 61:311
    • Recker F (2019) Sono4Students - A student sonography project. J Int Educ Pract 2019:18-23

    Information gemäß § 6 Medizinprodukte-Betreiberverordnung "Beauftragter für Medizinproduktesicherheit"

    Sehr geehrte Damen und Herren,

    gemäß § 6 Medizinprodukte-Betreiberverordnung steht Ihnen das Universitätsklinikum Bonn im Zusammenhang mit Meldungen über Risiken von Medizinprodukten, Informationen zu Rückrufen oder Warn- und Sicherheitshinweisen sowie bei der Umsetzung von notwendigen korrektiven Maßnahmen unter folgender E-Mailadresse zur Verfügung: Enable JavaScript to view protected content.

    Diese E-Mailadresse richtet sich vorzugsweise an Kontaktpersonen von Behörden, Herstellern und Vertreibern von Medizinprodukten.

    Unsere Webseite verwendet Cookies.

    Bei Cookies handelt es sich um Textdateien, die im Internetbrowser bzw. vom Internetbrowser auf dem Computersystem des Nutzers gespeichert werden. Ruft ein Nutzer eine Website auf, so kann ein Cookie auf dem Betriebssystem des Nutzers gespeichert werden. Dieser Cookie enthält eine charakteristische Zeichenfolge, die eine eindeutige Identifizierung des Browsers beim erneuten Aufrufen der Website ermöglicht. Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Einige Elemente unserer Internetseite erfordern es, dass der aufrufende Browser auch nach einem Seitenwechsel identifiziert werden kann.

    Unsere Webseite verwendet Cookies.

    Bei Cookies handelt es sich um Textdateien, die im Internetbrowser bzw. vom Internetbrowser auf dem Computersystem des Nutzers gespeichert werden. Ruft ein Nutzer eine Website auf, so kann ein Cookie auf dem Betriebssystem des Nutzers gespeichert werden. Dieser Cookie enthält eine charakteristische Zeichenfolge, die eine eindeutige Identifizierung des Browsers beim erneuten Aufrufen der Website ermöglicht. Wir setzen Cookies ein, um unsere Website nutzerfreundlicher zu gestalten. Einige Elemente unserer Internetseite erfordern es, dass der aufrufende Browser auch nach einem Seitenwechsel identifiziert werden kann.

    Ihre Cookie-Einstellungen wurden gespeichert.